🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Richard D. Kim

Moffitt Cancer Center

ORCID: 0000-0002-8448-844X
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer.

43 citations

Shannon McDonough, Anthony B. El-Khoueiry, Tanios Bekaii‐Saab, Stacey Stein, Vaibhav Sahai +9 more

24 citations

Prashant Dogra, Zhihui Wang, Mintallah Haider, Jasmina Ehab, Daniel Jeong +15 more

0 citations

Taymeyah Al‐Toubah, Emily Coughlin, Rahul Mhaskar, Sylea Lowery, Ebin Mathew +12 more

39 citations

Donghui Li, Younghun Han, Jinyoung Byun, Rikita Hatia, Erping Long +48 more

N/A
0DataRank · unranked
17 citations

Richard D. Kim, Aristidis Vasilopoulos, Eric A. Voight, Erik J. Alexanian, Jonathan N. Gruhin

1 citations

Vikram R. Shaw, Jinyoung Byun, Aaron P. Thrift, Catherine Zhu, Donghui Li +33 more

0 citations

Alexander Nguyen, Anastasiia K Tompkins, Kathleen S. Berfield, Richard D. Kim, Douglas E. Wood +18 more